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Abstract
Treating rats with kainic acid induces status epilepticus (SE) and leads to the development of behavioral deficits and
spontaneous recurrent seizures later in life. However, in a subset of rats, kainic acid treatment does not induce overt
behaviorally obvious acute SE. The goal of this study was to compare the neuroanatomical and behavioral changes induced
by kainate in rats that developed convulsive SE to those who did not. Adult male Wistar rats were treated with kainic acid
and tested behaviorally 5 months later. Rats that had experienced convulsive SE showed impaired performance on the
spatial water maze and passive avoidance tasks, and on the context and tone retention tests following fear conditioning. In
addition, they exhibited less anxiety-like behaviors than controls on the open-field and elevated plus-maze tests.
Histologically, convulsive SE was associated with marked neuron loss in the hippocampal CA3 and CA1 fields, and in the
dentate hilus. Rats that had not experienced convulsive SE after kainate treatment showed less severe, but significant
impairments on the spatial water maze and passive avoidance tasks. These rats had fewer neurons than control rats in the
dentate hilus, but not in the hippocampal CA3 and CA1 fields. Correlational analyses revealed significant relationships
between spatial memory indices of rats and neuronal numbers in the dentate hilus and CA3 pyramidal field. These results
show that a part of the animals that do not display intense behavioral seizures (convulsive SE) immediately after an
epileptogenic treatment, later in life, they may still have noticeable structural and functional changes in the brain.
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Introduction
Temporal lobe epilepsy (TLE) can be associated with hippo-
campal cell loss (hippocampal sclerosis) and other structural
changes in the medial temporal lobe region, such as fiber sprouting
and synaptic reorganization [1,2,3]. It has also been repeatedly
reported that TLE patients with hippocampal sclerosis may show
learning and memory deficits, increased anxiety, depression and
mood disorders [4,5,6]. Thus, it seems reasonable to assume that
these behavioral changes are secondary to the TLE-related
hippocampal neurodegeneration. However, it is also possible that
they are not so straightforwardly related to classical hippocampal
sclerosis, but may rather reflect some subtle functional or
structural alterations in neuronal circuits, either associated with
or even unrelated to epileptic seizures.
Most of the neuropathological aspects of TLE can be
reproduced using appropriate animal models. For example, many
studies have shown that the treatment of rats with kainic acid
(KA), a specific agonist for glutamate receptors, induces acute
status epilepticus (SE), accompanied by severe convulsive (motor)
seizures, and that later in life these animals show spontaneous
recurrent seizures, hippocampal cell loss and memory deficits
[7,8,9]. However, in this epilepsy model some rats are consider-
ably more resistant to KA-induced convulsive SE than the others
and, for that reason, are usually excluded from the studies
[9,10,11,12,13]. Thus, given that the research on the neuronal
effects of KA in this subset of animals has been scarce [14], which
represents an important gap in the understanding of epilepsy-
related neuropathology, the present study was designed to directly
compare the behavioral and neuroanatomical outcomes in rats
that developed convulsive SE after kainate treatment to those that
did not. We thought that the presence of behavioral deficits in KA-
treated rats that had not experienced convulsive SE would support
the hypothesis that at least some of the behavioral impairments
seen in epilepsy can be explained by relatively mild structural or
functional changes in the hippocampal region. To address this
issue, we assessed the behavioral profile of KA-treated rats of both
phenotypes using the Morris water maze [15], passive avoidance
and fear conditioning tests, as well as in the open field and elevated
plus maze tests. Additionally, absolute numbers of neurons in the
dentate gyrus hilus and pyramidal layers of the hippocampus
proper were estimated using stereological approaches in order to
compare the hippocampal cell loss between the two groups.
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Materials and Methods
The handling and care of the animals were conducted
according to the ‘‘Principles of laboratory animal care’’ (NIH
publication No. 86-23, revised 1985) and Directive 2010/63/EU
of the European Parliament and of the Council of 22 September
2010 on the protection of animals used for scientific purposes. The
experimental protocol has been approved by the Ethics Commit-
tee of the Faculty of Medicine of Porto and the General Veterinary
Direction (03.04.2012) for the FCT application grant PTDC/
SAU-NSC/115506/2009. All efforts were made to minimize the
number of animals used and their suffering.
Animals and Treatments
Male Wistar rats, maintained under standard laboratory
conditions, were used in this study. At 10 weeks of age (mean
body weight 323669 g), they were randomly divided into two
groups: KA group (n = 28) and control group (n = 8). In the first
group, rats were treated with KA according to the protocol
developed by Dudek and coworkers and described in detail
elsewhere [16,17]. Briefly, the rats were injected every hour with
5 mg/kg of KA (i.p., Sigma) until the onset of convulsive SE,
which was defined as the appearance of behavioral symptoms
corresponding to stage 3, 4 or 5 seizures on the Racine scale [18],
i.e. forelimb clonus, rearing, and rearing with falling. When
necessary, treatment was continued in order to assure that SE
lasted for at least 3 hours. All rats in this group demonstrated
numerous wet-dog-shake seizures after either the second or third
injection of KA. The SE, lasting 3–6 hours, was detected in 17 rats
after 3–5 injections, with the mean cumulative dose of KA equal to
2163 mg/kg. These rats were ascribed to the ‘‘behavioral status
epilepticus’’ group (BSE; n = 17). Remaining 11 rats after 4 to 6
KA injections either became motionless (unchanged position in the
observation cage for tens of minutes, weak reactivity to touching
by experimenter’s hand), or showed excessive activity (long runs,
jumping). Because we and others [17] have previously observed
that continuation of the treatment of animals in these states often
leads to their death, the treatment was terminated. The mean
cumulative dose of KA received by these rats, which were ascribed
to the ‘‘no behavioral status epilepticus’’ group (no-BSE; n = 11)
was 2464 mg/kg. It was previously reported that the treatment
protocol employed in our study is associated with a relatively low
mortality rate of the animals when compared to the single high-
dose kainate treatments [16,17]. However, because animal
mortality is a prominent cause of bias in quantitative evaluation
of neuronal loss [19], special efforts were made in order to further
improve the survival rate in the kainate-treated rats. In particular,
the animals were periodically injected with saline (s.c.) during the
first 48 hours of the recovery period. On the following days, the rat
diet was supplemented with apples that were sliced and left at the
bottom of the cage. The rats that refused to eat or drink were
hand-fed using a plastic syringe. Rats in the control group were
injected with saline.
Following the treatments, all animals were given a 5-month
recovery period. In the last week of each month, the behavior of
rats in their home cages was videorecorded during the light phase
of the 12-h light/dark cycle (between 08:00 h and 20:00 h) over a
period of 5 consecutive days. The recording was performed using
the multichannel video-tracking system EthoVision 8.5 (Noldus,
The Netherlands). The video files generated by the system and
stored on the hard disk of the computer were then analyzed in a
fast-motion mode by a person blind to treatment groups using the
VLC media player (VideoLAN, France). In addition, the rats were
daily (except weekends) observed for spontaneous behavioral
seizures during 1-h intervals between 09:00 h and 10:00 h, as well
as during all the procedures associated with handling and
behavioral testing.
Open-field and Elevated Plus-maze Tests
Behavioral testing began when animals were 7 months old.
Animals were handled 3 minutes per day during 5 days and
subjected to the open-field test and plus-maze as previously
described in detail [20]. The rats were counterbalanced so that, in
each group, half received the open-field test first and the other half
received the plus-maze test first. There was a 3-day interval
between the two tests.
The behavior of rats in the open field (1006100640 cm) was
tested during 5-minute sessions. Distances traveled in the outer
zone of the open field, defined as 20 cm from any wall, and in its
inner zone were measured using the computerized EthoVision
video-tracking system.
The elevated plus maze was arranged as a cross with two
opposite open and two opposite closed arms (50612 cm),
connected by a common central square (12612 cm). The rats
were allowed to explore the apparatus for 5 minutes. Behavior of
rats was recorded and analyzed using the video-tracking system.
The percentages of time spent by rats in the open arms, closed
arms, and in the central square were measured. The number of
entries into the arms of the apparatus was also registered.
Step-through Passive Avoidance and Fear Conditioning
Following a 3-day interval, all rats were submitted to the passive
avoidance and fear conditioning tests. The rats were counterbal-
anced so that, in each group, half received the passive avoidance
test first and the other half received the fear conditioning first.
There was a 3-day interval between the two tests.
The apparatus used in the passive avoidance task was comprised
of two adjacent compartments separated by a guillotine door [20].
The larger compartment (45645645 cm) was brightly lit and the
smaller compartment (30616616 cm) was dark. The floor of both
compartments was composed of stainless steel bars, 0.5 cm in
diameter and spaced 1.2 cm apart, but only the floor of the dark
compartment was wired to the stimulus generator (Hugo-Sachs
Elektronik, Germany). On the first day, the rats were allowed to
explore the apparatus with the guillotine door open for 5 minutes.
The following day, each rat was placed into the brightly lit
compartment and the latency to enter into the dark compartment
was recorded. Upon entry into the dark compartment, the door
was lowered and a 1-mA, 1-s footshock was delivered 3 times at 5-s
intervals. Twenty four hours later, this procedure was repeated,
with the exception that no footshock was delivered, and the
latency to enter the dark compartment was again recorded.
All rats were given a single session of fear conditioning as
previously described in detail [20]. The conditioning chamber
(San Diego Instruments, USA) was equipped with a metal grid
floor, wired to the stimulus generator and acoustic stimulus unit.
The grid floor was composed of stainless steel bars, 0.6 cm in
diameter, spaced 1.4 cm apart. The chamber was scented with 1%
acetic acid solution (placed into base pan underneath the grid
floor) in order to provide a distinct context odor. Rats were placed
inside the apparatus and left undisturbed for 3 minutes. During
next 3-minute period they received 5 tone-footshock conditioning
trials, with 30-s intervals. Each conditioning trial consisted of a 10-
s tone conditioned stimulus (80 dB, 2.8 kHz), which coterminated
with a 1-s footshock unconditioned stimulus (0.8 mA) delivered via
the grid floor.
One day later, all rats were submitted to retention tests. The
order of testing was counterbalanced so that half of the rats in each
Behavioral Deficits in Kainate-Treated Rats
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group were tested for retention of the conditioned context by
repeating the procedure employed during training (in the absence
of the tone or footshock), whereas remaining rats were tested for
retention of the conditioned tone in a different context. In the later
test, the rats were placed into a novel chamber which was located
in a novel behavioral room. The floor of the new chamber was
composed of a piece of a black carpet. The chamber was scented
with lemon instead of acetic acid. The animals remained in the
chamber for a period of 6 minutes and the conditioned stimulus
(10-s tone) was presented 5 times during the last 3 minutes of this
period. Four hours later, these rats were tested for retention of the
context as described above, whereas the animals from the context
test were now subjected to the tone retention test.
All training and testing trials were recorded with a video camera
connected to a SVHS recorder for subsequent analysis. The rat’s
behavior was analyzed by an observer blinded with respect to
experimental group. Freezing (defined as the absence of all
movement other than that required for breathing) was scored if the
rat remained inactive for at least 3 seconds. The percentage of
accumulated time spent freezing was calculated.
Morris Water Maze Test
The procedure of the water maze training, previously described
in detail [21], initiated one week following the termination of the
passive avoidance and fear conditioning tests. The maze consisted
of a black circular tank, 180 cm in diameter and 50 cm deep, and
was located in a corner of a room containing extramaze cues. The
apparatus was filled with water at room temperature (2161uC) to
a depth of approximately 35 cm. The water was made opaque by
adding a non-toxic paint. The maze was divided, by imaginary
lines, into four equal-size quadrants. An escape platform, 10 cm in
diameter, was placed in the center of one of the quadrants. It was
located 2 cm below the surface of the water. The animals were
trained to find the escape platform during 14 consecutive days
with two 60-s daily trials separated by a 30-s inter-trial interval.
Each rat was placed in the water facing the pool wall at one of the
four starting points that were used in a pseudo-random order so
that each position was used once in each block of four trials.
However, in each trial the starting positions were the same for all
animals. If the rats did not find the escape platform within 60 s,
the experimenter guided them to the platform where they were
allowed to remain for 15 s. The platform location was not changed
during the 14-day training period. The swim path length and swim
speed were registered using the EthoVision video-tracking system.
One day after completion of the acquisition, animals were
submitted to a single 60-s probe trial in which the platform was
removed from the pool. The number of times the rats swam
through the zone where the platform had been located (platform
crossings) and the percentage of time spent by rats swimming in
the training quadrant were recorded.
Performance of animals on the visible platform task was assessed
during a 2-day period. The rats were given 1 block of 4 trials per
day separated by 30-s inter-trial intervals. The platform, painted in
white, was exposed 3 cm above the water surface. The position of
the platform was different in each trial. The distances swum to
locate the platform were recorded and averaged across 8 trials.
Tissue Preparation
Following the completion of the behavioral experiments, six
animals in each group, selected at random, were deeply
anesthetized with pentobarbital (90 mg/kg) and injected intracar-
dially with 0.1 mL of a heparin solution, followed by 1 mL of 1%
sodium nitrite in saline. Then, they were perfused transcardially
with 150 mL of 0.1 M phosphate buffer (pH 7.4) for vascular
rinse, followed by 250 mL of a fixative solution containing 4%
paraformaldehyde in phosphate buffer. The brains were removed
from the skulls, immersed for 2 hours in the fixative, and infiltrated
during 36 h in 10% sucrose solution at 4uC. After the frontal poles
were trimmed away, the blocks were mounted on a vibratome and
sectioned in the coronal plane at 40 mm. Every sixth section
containing the hippocampal formation was collected using a
systematic random sampling procedure [22], which provided an
average of 14 sections per animal, mounted serially on gelatin-
coated slides and air-dried. The sections were stained with a
Giemsa, dehydrated in a series of ethanol solutions (50%, 70%,
90% and 100%) and coverslipped using Histomount (National
Diagnostics, Atlanta, GA, USA).
Morphological Analysis
The Giemsa-stained tissue sections were visualized and imaged
using an Axio Scope.A1 microscope equipped with a AxioCam
MRc5 digital camera (Zeiss, Germany). The total numbers of
neurons were estimated by applying the optical fractionator
method [23]. The boundaries of the hilus of the dentate gyrus and
of the CA3 and CA1 hippocampal fields were consistently defined
at all levels along the rostrocaudal axis of the brain on the basis of
cell morphology and cytoarchitectonic criteria [24]. Neurons
belonging to the CA2 hippocampal field were included in the CA3
region. Estimations were carried out using the C.A.S.T.-Grid
System (Olympus, Denmark). Beginning at a random starting
position, visual fields were systematically sampled along the x and
y axes, using a raster pattern procedure. Neurons were counted in
every frame using the optical disector at a final magnification of
62,000. Tissue thickness was estimated at each counting frame
and guard zones of 2 mm were implemented. The nucleus of the
neurons was used as the counting unit. The coefficient of error
(CE) of the individual estimates was calculated according to
Gundersen et al. [25] and it ranged between 0.06 and 0.09.
Statistical Analysis
Before conducting statistical comparisons, data were tested for
normality using the Shapiro-Wilk’s W test, which is known to be
the most powerful normality test, especially in the case of small
sample sizes [26]. Because all data samples passed the normality
test (p.0.05), they were analyzed for statistical significance using
parametric tests. Data derived from the passive avoidance test,
acquisition trials of the water maze task, and training trials and
tone retention trials of the fear conditioning test were analyzed
using repeated measures ANOVA. The remaining data were
analyzed using one-way ANOVA. Newman-Keuls post hoc test
was used where appropriate. Because some of the behavioral tests
were presented in a counterbalanced manner, the data derived
from these tests were collapsed across order of presentation.
Pearson’s product moment regression model was used to analyze
correlations between the neuron numbers and the two behavioral
indices derived from the water maze test: the percentage of savings
assessed by the difference in the mean distance swum between the
first four trials and the last four trials (index of learning), and the
percentage of time spent by rats swimming in the quadrant where
the platform had been located during training (index of retention).
All behavioral data are presented as the mean6SEM, while
morphological results are expressed as the mean6SD. Differences
were considered as significant at the p,0.05 level.
Behavioral Deficits in Kainate-Treated Rats
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Results
Monitoring during the Recovery Period
Despite all the efforts made to reduce the mortality rate in KA-
treated rats (see above), a significant proportion of them have died
during the recovery period. In particular, from the 17 rats that had
experienced convulsive SE 3 rats have died within 48 h following
the treatment and 3 rats have died during the first month of the
recovery period. From the 11 rats that did not show motor
manifestations of SE 2 rats have died within 48 h following the
treatment. Repeated behavioral seizures of stage 3 to 5 on the
Racine scale were observed in a total of 9 rats: by the end of the
first month of recovery – in just 1 rat; by the end of the second and
third months – additionally in 3 and 5 rats, respectively.
Interestingly, during the treatment with KA, all of these rats
showed a typical pattern of behavioral SE, that is, continuous stage
3 to 5 seizures on the Racine scale. Three of the rats in this group
had motor seizure attacks during the behavioral tests: 1 rat –
during the water maze training (twice) and 2 rats during the tone
test of the fear conditioning procedure. The respective trials were
repeated for these animals on the next day. None of the rats had
motor seizures during the 1-h intervals preceding or following the
behavioral tests. The remaining 2 rats, which experienced
convulsive SE during the treatment with KA, showed no
spontaneous stage 3, 4 or 5 seizures during the entire 6-month
observation period (including the period of behavioral tests).
However, one of the experimenters detected in these 2 rats
repeated mouth and facial movements (stage 1 seizures on the
Racine scale), but this observation was not confirmed by other
experimenters. Thus, the final group size for BSE rats was n = 11.
No signs of behavioral seizures (stages 1–5 on the Racine scale)
were detected in the remaining 9 KA-treated rats. These rats, in
contrast, did not show clearly expressed motor signs of SE during
the treatment with KA (no-BSE group; final n = 9). No behavioral
abnormalities were observed in the control group.
Behavioral Effects of KA Treatment in the Open-field and
Elevated Plus-maze
The results obtained in the open-field tests are shown in Fig. 1A.
ANOVA revealed a significant effect of the treatment on the
locomotion activity of rats both in the outer zone of the apparatus
(F2,25 = 4.70, p,0.05) and in its inner zone (F2,25 = 4.07, p,0.05).
Post-hoc comparisons showed that animals from BSE group
traveled significantly longer distances in the peripheral zone of the
open field than did control rats and no-BSE rats (p,0.05).
Similarly, rats from BSE group showed increased locomotion in
the inner part of the open field. However, in this zone, the
difference was significant only when BSE group was compared to
no-BSE group (p,0.05), but it did not reach the level of
significance when compared to control group (p= 0.08).
Rats in all groups showed clear preference to protected areas of
the plus maze, as they spent more time in the closed arms and
central zone of the apparatus in comparison to its open arms
(Fig. 1B). However, although the percentages of time spent by rats
in the closed arms and central zone did not differ between the
groups (Fs,1, p.0.05), ANOVA revealed a significant effect of
the treatment on the time spent by rats in the open arms
(F2,25 = 3.31, p,0.05). Particularly, rats in the BSE group spent
significantly more time in the open arms than those from control
group and no-BSE group (p,0.05). No significant differences were
detected between the groups regarding the total number of entries
into the arms of the apparatus.
Effects of KA Treatment on Passive Avoidance and
Conditioned Freezing Behavior
The results of the passive avoidance testing are shown in Fig. 2.
Repeated measures ANOVA did not reveal a significant main
effect of treatment on the performance of rats on this task
(F2,25 = 1.47, P= 0.25). However, there was a significant effect of
training (F1,25 = 14.30, p,0.001) and a significant interaction
between these two effects (F2,25 = 5.09, p,0.01). Post-hoc
comparisons showed that, although rats in no-BSE group did
not differ from control rats in the baseline latency to enter the dark
compartment, on the retention trial, the entry latencies were
significantly reduced in this group relative to controls (p,0.05).
The latencies to enter the dark compartment on the retention test
were not significantly different between control group and BSE
group. However, the baseline latency was significantly increased in
BSE rats relative to control rats (p,0.05), suggesting that the high
entry latencies registered in this group on the retention test might
be related to a decreased motivation to enter the dark
compartment of the apparatus, for example, due to reduced levels
of anxiety.
Conditioning produced an increase in the amount of freezing
time in either group (F1,25 = 156.11, p,0.0001; Fig. 3A) and
examination of the data revealed no significant differences
between the groups. Once placed into the training chamber 1
Figure 1. Behavior of kainate-treated rats in the open-field (A)
and elevated plus-maze (B) tests. The y-axis represents the
distances travelled by rats during the 5-min testing sessions in the
outer and inner zones of the open-field apparatus, and in the central
zone and open and closed arms of the plus-maze apparatus. Note that
rats who had experienced behavioral status epilepticus (BSE group)
traveled longer distances in the outer and inner zones of the open field
when compared to control rats and rats that had not experienced
behavioral status epilepticus (no-BSE group), respectively. In the plus-
maze test, rats in the BSE group spent more time in the open arms of
the apparatus than rats in the other two groups. *p,0.05 vs. control
group and #p,0.05 vs. no-BSE group. Data are presented as the
mean6SEM.
doi:10.1371/journal.pone.0084722.g001
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day later, the animals from all groups displayed increased levels of
freezing behavior (Fig. 3B). However, the amount of freezing
differed between the groups (F2,25 = 4.68, p,0.05), so that rats in
the BSE group froze to the familiar context significantly less than
control rats and no-BSE rats (p,0.05). However, no-BSE and
control groups did not differ significantly in this test. In the novel
context, the levels of freezing displayed by all groups in the
absence of the tone were inferior to those observed during the tone
presentation (F1,25 = 99.42, p,0.0001; Fig. 3C). Repeated-mea-
sures ANOVA of these data did not reveal a significant main effect
of treatment, but yielded a significant treatment by tone
presentation interaction (F2,25 = 3.29, p,0.05). Post-hoc tests
showed that, although in the absence of the tone the 3 groups
did not differ with respect to the amount of freezing, during the
tone presentation, the rats in BSE group showed relatively low
levels of fear, freezing significantly less than control rats (p,0.05).
Water Maze Navigation
The mean distances swum by rats in the control, BSE and no-
BSE groups to locate the hidden platform in the place learning
task are presented in Fig. 4A. The statistical analysis by repeated
measures ANOVA showed that the rats included in this
experiment progressively improved their ability to find the
platform over the 14 days of acquisition (F6,150 = 25.980
p,0.00001). However, the overall performance of the rats on this
task differed among the groups studied, as indicated by a
significant main effect of treatment (F2,25 = 12.89, p,0.0001) and
significant treatment 6 trial block interaction (F12,150 = 1.86,
p,0.05). Post-hoc tests for the main effect of treatment revealed
that animals from the BSE group and no-BSE group performed
the task less well than did control animals (p,0.001 and p,0.01,
respectively), but animals in the BSE group were more severely
impaired than those in the no-BSE group (p,0.05). Post-hoc tests
for the treatment6 trial block interaction showed that BSE group
performed significantly worse than control group on the 2nd to 7th
trial blocks (p,0.0001). In turn, rats in the no-BSE group also
traveled greater distances than did control rats on the 2nd to 7th
trial blocks (p,0.001). Moreover, rats from the BSE group were
less efficient in finding the escape platform than rats from the no-
BSE group on the 4th, 5th, and 7th trial blocks (p,0.05).
Behavioral measures obtained on the probe trial are shown in
Fig. 4B. ANOVA revealed a significant effect of treatment on the
total percentages of time spent by rats swimming in the training
quadrant (F2,25 = 7.01, p,0.01) and a significant effect of
treatment on the number of times they crossed the former location
of the escape platform (platform crossings; F2,25 = 6.40, p,0.01).
Post-hoc tests showed that both control and no-BSE rats spent
more time in the training quadrant than did rats in the BSE group
(p,0.01 and p,0.05, respectively). However, the no-BSE group
did not differ from the control group on this measure, suggesting
Figure 2. Performance of kainate-treated rats on the passive
avoidance test. The y-axis represents the mean (6SEM) step-through
latencies during training trial as well as on the retention trial given 24 h
later. Note that rats which did not show behavioral signs of status
epilepticus following the treatment with kainate (no-BSE group)
showed lower retention scores than did control rats. In contrast, rats
that had experienced behavioral status epilepticus (BSE group) showed
increased baseline entry latency, but appeared normal on the retention
test. *p,0.05 vs. control group.
doi:10.1371/journal.pone.0084722.g002
Figure 3. Effects of kainate treatment on the acquisition and
retention of conditioned fear. The y-axes represent percentage of
freezing time for each of the 3-minute periods of the acquisition session
(A), during the context retention test (B), and during each of the 3-
minute periods of the tone retention test which was performed in a
novel context (C). No tone or footshock was delivered during the first 3-
minute periods of the acquisition session (A) and of the tone retention
test (C). Note that rats that had experienced behavioral status
epilepticus (BSE group) showed reduced levels of fear, freezing
significantly less than control rats on both retention tests. However,
no-BSE group (composed of rats that had not experienced behavioral
status epilepticus after kainate treatment) and control group did not
differ significantly on these tests. *p,0.05 vs. control group and
#p,0.05 vs. no-SE group. Data are presented as the mean6SEM.
doi:10.1371/journal.pone.0084722.g003
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that rats in both these groups, unlike those in the BSE group, were
able to learn a spatial strategy when searching for the escape
platform. Nevertheless, the acuity of spatial search was impaired in
both KA-treated groups, as indicated by the fact that control rats
crossed the former platform position more frequently when
compared to both BSE group (p,0.01) and no-BSE group
(p,0.05).
ANOVA revealed that there was a significant main effect of
treatment on the speed of swimming averaged across all trials of
the water maze acquisition (F2,25 = 3.29, p,0.05). The animals
from the BSE and no-BSE groups swam somewhat faster than
control rats (24.761.2 and 22.361.5 cm/s vs. 20.161.1 cm/s,
respectively). However, only BSE rats differed significantly from
control rats on this measure (p,0.05). Animals in all groups were
able to learn the visible platform task. The distances swum to
locate the platform, averaged over eight trials, were 3986102 cm
in the control group, 5136115 cm in the BSE group and
466695 cm in the no-BSE group. ANOVA failed to reveal a
significant effect of treatment on this parameter. These data
indicate that, with respect to sensorimotor functions, KA-treated
rats were not impaired when compared to control rats.
Effects of KA Treatment on Hippocampal Morphology
Representative photographs of brain sections illustrating treat-
ment-related morphological changes in the hippocampal forma-
tion of rats in the BSE and no-BSE groups are shown in Fig. 5 and
Fig 6. The qualitative observation of the sections inferred that the
neuronal density of the CA3 and CA1 pyramidal cells was
considerably smaller in BSE-rats than in control rats and no-BSE
rats. In some hippocampal regions, CA1 pyramids were practically
absent in BSE rats (Fig. 5B). In addition, the dentate gyrus was
deformed and its granule cell layer was dispersed in animals that
experienced behavioral SE. Consistent with prior anatomical
studies [27,28], the density of hilar neurons in control rats was
higher in the sections obtained from the temporal (ventral) pole of
the dentate gyrus when compared to those obtained from its septal
(dorsal) pole (Fig. 5A and Fig. 6A). The density of hilar neurons
was reduced in KA-treated rats that experienced convulsive SE
throughout the entire dentate gyrus, but neuron loss was
particularly extensive in the ventral hilus (Fig. 6B). However, in
rats from the no-BSE group hilar neuron loss was less extensive
and most of the neurons of the ventral hilus were preserved
(Fig. 6C).
The estimates of the total numbers of neurons in the hilus of the
dentate gyrus, and in the CA3 and CA1 fields of the hippocampus
proper are shown in Fig. 7. Analysis of these data revealed that
there was a significant main effect of seizures on neuron numbers
in all three hippocampal subdivisions: dentate hilus (F2,15 = 6.77,
p,0.01), pyramidal CA3 field (F2,15 = 31.13, p,0.0001) and
pyramidal CA1 field (F2,15 = 30.72, p,0.0001). Post-hoc compar-
isons showed that in rats in which KA treatment resulted in the
development of behavioral SE there was a significant neuron loss
in the dentate hilus (40%; p,0.01), and hippocampal CA3 (50%;
p,0.001) and CA1 (80%; p,0.001) fields. In sharp contrast, in
rats from the no-BSE group there was a significant neuron loss
only in the dentate hilus (30%; p,0.05), but not in the
hippocampal pyramidal fields.
Relationship between KA-induced Neuron Loss and
Spatial Learning and Memory
Correlational analyses were conducted to determine whether
individual variations in learning and memory abilities of rats are
related to KA-induced loss of hippocampal neurons. The analyses
were conducted separately for hilar neurons, and CA3 and CA1
hippocampal pyramidal neurons. Data obtained from 6 animals
from each group, whose brains were randomly selected for
histological assessment, were included in the analysis (final n = 18).
The results of the correlational analyses, shown in Fig. 8, revealed
significant correlations between the total number of hilar neurons
and two behavioral indexes of spatial learning and memory, i.e.
the percentage of savings between the first four trials and the last
four trials of the water maze acquisition (r= 0.57, p,0.01; Fig. 8A)
and the percentage of time spent in the training quadrant during
the probe trial (r= 0.49, p,0.05; Fig. 8B). Interestingly, both
behavioral measures tend to exhibit even stronger correlations
Figure 4. Effects of kainate treatment on the performance of
rats on the water maze. (A) The y-axis represents the mean swim
distance (6SEM) in centimeters to reach a hidden platform throughout
the acquisition of the water maze task. The data were averaged across
seven blocks of four consecutive trials each (the x-axis). Note that the
performance of rats that had experienced behavioral status epilepticus
(BSE group) on this task was extremely poor. However, spatial learning
of the rats that showed no convulsive status epilepticus (no-BSE group)
was also considerably impaired. *p,0.0001 for BSE group vs. control
group and p,0.001 for no-BSE group vs. control group; #p,0.05 vs. no-
BSE group. (B) The y-axes represent the percentage of time spent by
rats in the training quadrant of the water maze during the probe trial
and the number of times they swam through the zone where the
platform had been located (platform crossings). Unlike control rats, rats
in the BSE group did not show a preference for the training quadrant of
the water maze and were impaired in their ability to localize the former
platform position. However, the acuity of spatial search was also
impaired in the no-BSE rats, as indicated by the fact that they crossed
the former platform position less frequently than did control rats.
*p,0.05 for no-BSE group vs. control group and p,0.01 for BSE group
vs. control group; #p,0.05 vs. no-BSE group. Data are presented as the
mean6SEM.
doi:10.1371/journal.pone.0084722.g004
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with the total number of neurons in the CA3 hippocampal field
(r= 0.74, p,0.0005 and r= 0.6, p,0.01 for the percentage of
savings and percentage of time in the training quadrant,
respectively; Fig. 8C, D). In contrast, we found no significant
correlations between the two behavioral indexes and the total
number of the CA1 pyramidal neurons (Fig. 8E, F).
Figure 5. Effects of kainate treatment on hippocampal
morphology. Photomicrographs of representative Nissl-stained coro-
nal sections containing the dentate gyrus, CA3 and CA1 hippocampal
fields taken from a control rat (A), from a rat in the behavioral status
epilepticus (BSE) group (B) and from a kainate-treated rat that had not
experienced behavioral status epilepticus (no-BSE; C). Note that the
density of neurons in the dentate hilus is considerably reduced in the
rats with (B) and without (C) behavioral SE when compared to the
control rat (A). Note also dramatic loss of the CA3 and especially CA1
neurons in the rat from the BSE group; neurons in the CA2 field are
relatively preserved (B). Scale bar shown in (B) = 200 mm.
doi:10.1371/journal.pone.0084722.g005
Figure 6. Kainate-induced loss of neurons in the ventral
dentate hilus. Photomicrographs of representative Nissl-stained
coronal sections containing the ventral portion of the dentate gyrus
taken from a control rat (A), from a rat in the behavioral status
epilepticus (BSE) group (B) and from a kainate-treated rat that had not
experienced behavioral status epilepticus (no-BSE; C). Note that the
density of neurons in the dentate hilus is dramatically reduced in the rat
that experienced behavioral SE (B). In striking contrast, most of the
neurons of the ventral hilus are preserved in the rat from the no-BSE
group (C). Scale bar shown in (B) = 250 mm.
doi:10.1371/journal.pone.0084722.g006
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Discussion
The results of this experiment show that rats treated with similar
doses of KA may have two quite distinct sets of brain changes. In
particular, the neuropathological sequelae of the treatment were
different in the following ways: (1) in one group of rats KA induced
a clear pattern of convulsive SE including repeated stage 4 and 5
seizures on the Racine scale, but this was not observed in
remaining rats; (2) majority of the rats that had experienced
behavioral SE developed spontaneous motor seizures 1 to 3
months later, whereas the rats in the other group did not; (3)
histological analysis revealed massive loss of hippocampal pyra-
midal neurons in rats that had experienced behavioral SE,
whereas no pyramidal cell loss was detected in rats who did not
show motor signs of SE; in either group of KA-treated rats, the
total number of neurons in the hilus of the dentate gyrus was
reduced; (4) although rats in both KA-treated groups were
impaired in behavioral tests, the impairments were significantly
more profound and wide-ranging in the BSE group. These data
are consistent with previous studies showing that animals of the
same strain may have different seizure susceptibility [14,29,30,31],
which is believed to have both genetic [29,30] and environmental
[32] underpinnings.
Rats in the BSE group were not only impaired in learning the
precise platform position in the water maze, but were, in fact,
unable to adopt a spatial strategy to solve the task. In addition,
they showed severely impaired performance on the passive
avoidance task and on the fear conditioning tests. Rats in this
group were hyperactive in the open-field test and spent more time
walking on the open arms of the elevated plus maze, suggesting a
deficient emotional responsiveness. Our results are consistent with
many prior studies in which behavioral changes were detected in
animals following SE induced by either electrical stimulation
[11,33] or injections of chemoconvulsants (pilocarpine [34,35],
lithium-pilocarpine [9,13,36], and kainate [8,9,11,12,13,37,38]
models). However, the behavioral deficits observed in the present
study appear to be somewhat more pronounced than those
reported in prior studies using the same model of SE [9,39,40].
This discrepancy is likely due to differences in experimental
conditions between different studies. For example, it has been
reported that the induction of SE in adult rats is followed by more
robust behavioral deficits than in premature rats [8,37,38] and
that old rats, in turn, are more susceptible to SE when compared
to adult rats [12]. In addition, it has been shown that the seizure-
related behavioral impairments are strain-specific [9,13,31,41].
Furthermore, it is also well documented that different treatment
protocols, e.g. duration of SE, may be associated with very
different neuropathological outcomes in experimental animals
[9,16,42]. It may be also noted that we performed behavioral
testing of rats approximately 5 months after the induction of SE,
that is, at a time when seizure frequency is maximal [43]. For
comparison, studies on animals just 2 or 3 months post-SE, when
seizures are relatively less frequent and neuroanatomical changes
are likely to be less dramatic, generally reveal less severe
behavioral deficits [9,40]. However, it remains to be seen whether
SE-related behavioral deficits actually worsen with increased
duration of epileptic state. In fact, it has been recently reported
that animals tested two months and twenty months after the
induction of SE showed similar cognitive impairments [44].
There are a few prior studies in which animals that did not
develop convulsive SE after the respective treatments were
evaluated behaviorally in parallel to those who did. In particular,
Szyndler et al. [36] reported that lithium-pilocarpine-treated rats
resistant to develop SE did not differ behaviorally from control
rats, whereas rats that developed SE were impaired in the fear
conditioning and open-field tests. Mu¨ller et al. [34] have shown
that pilocarpine-treated mice without motor signs of SE differed
significantly from control mice in several measures derived from
the open-field, hole-board and light-dark transition tests (mainly
related to their increased activity), but were intact, unlike mice
which had behavioral SE, on the elevated plus-maze, novel object
exploration and spatial water maze tests. However, histological
analysis carried out in the latter study revealed significant loss of
hippocampal neurons only in mice that developed convulsive SE
[34]. Interestingly, it has been also reported that treating rats with
KA during early postnatal period induces electrographic and mild
behavioral seizures, but does not evoke a typical pattern of SE, i.e.
stage 4–5 seizures on the Racine scale [37,38]. Yet, later in life,
these rats show significant cognitive deficits accompanied by long-
term impairments in hippocampal plasticity [37,38]. In this
respect, it is worth noting the results of a recent study by Sua´rez
et al. [14] who reported that treating rats with KA, even if it
induces neither motor SE, nor spontaneous seizures later in life,
may lead to enduring changes in synaptic plasticity. In the present
study, KA-treated rats that did not develop motor SE had cell loss
in only one of the hippocampal subdivisions, the dentate hilus, but
were impaired on the passive avoidance and spatial water maze
tasks. Thus, taken together, these findings indicate that a part of
the animals that do not manifest intense behavioral seizures
immediately after an epileptogenic treatment, later in life, they
may still have conspicuous structural and functional changes in the
brain.
It is well documented that epilepsy models based on the
induction of SE are typically associated with marked neuronal loss
in various brain regions, such as the hippocampal formation,
amygdala, thalamus, piriform, entorhinal, perirhinal, retrosplenial
and olfactory cortices [7,9,10,11,33,35,45,46,47], many of which
are implicated in cognitive and emotional processes
[15,48,49,50,51,52]. Therefore, it is likely that brain damage
induced by SE and subsequent spontaneous seizures is directly
responsible for the behavioral deficits observed in these models. In
Figure 7. Loss of hippocampal neurons in kainate-treated rats.
The y-axes represent the total numbers of neurons (mean6SD) in the
dentate hilus and hippocampal CA3 and CA1 pyramidal fields in control
rats and in kainate-treated rats with and without behavioral status
epilepticus (BSE group and no-BSE group, respectively). The number of
hilar neurons is reduced in both groups of kainate-treated rats when
compared to control group. Note that the number of cells in the CA3
and CA1 pyramidal regions was strikingly reduced in rats from the BSE
group, but not in those from the no-BSE group. Dentate hilus: *p,0.05
for no-BSE group vs. control group and p,0.01 for BSE group vs.
control group; CA3 and CA1 fields: *p,0.001 vs. control group and
#p,0.001 vs. no-BSE group.
doi:10.1371/journal.pone.0084722.g007
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effect, it has been recently shown that hippocampal volume of
epileptic rats significantly correlates with their learning and
memory abilities [9,53]. Similar relationships were found between
the volumetric estimates of the amygdala and the indices of
emotionality [9,53]. In this study, we detected marked loss of
hippocampal CA3 and CA1 pyramidal neurons in rats that had
Figure 8. Correlations between hippocampal neuron numbers and spatial learning and memory indices. The x-axes represent the total
numbers of neurons in the dentate hilus (A, B), and hippocampal CA3 (C, D) and CA1 (E, F) pyramidal fields in control and kainate-treated rats. The y-
axes represent the percentages of savings during water maze training, i.e. the differences, in %, between the mean distances swum by rats on the first
four trials and on the last four trials (A, C, E), and the percentages of time spent by rats in the training quadrant of the water maze during the probe
trial (B, D, F). Data obtained from 6 animals randomly selected from each group (final n = 18) were used in the correlational analyses. Correlation
coefficients are shown at the bottom of each plot and dashed lines represent 95% confidence intervals.
doi:10.1371/journal.pone.0084722.g008
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experienced behavioral SE, whereas in rats without behavioral
manifestations of SE these neuronal populations were preserved.
However, the loss of hilar neurons was detected in both KA-
treated groups, even though it was predictably greater in BSE
group than in no-BSE group. Thus, our data suggest that hilar cell
loss alone may be sufficient to cause functional deficits in
hippocampal circuits as indicated by the impaired performance
of no-BSE rats on the water maze and passive avoidance tests.
This suggestion is consistent with the evidence that hilar neurons
may influence mnemonic processes by synchronizing the activity
of the dentate gyrus granule cells and, more generally, by
modulating the transmission of information from the entorhinal
cortex to the hippocampal pyramidal fields [54,55]. This
possibility is also supported by the results of the correlational
analyses which revealed significant correlations between individual
spatial memory indices of rats used in this experiment and the total
number of hilar neurons, but not of CA1 pyramidal neurons. The
strongest correlation, however, was found between the cognitive
indices and the total number of CA3 neurons. This result may
appear surprising given that significant neuronal loss in this region
was observed in only one of the KA-treated group, namely in rats
that had experienced convulsive SE. However, it is possible that
even small loss of CA3 neurons, perhaps, undetectable in small-
size samples (such as those used in the present study), may have a
substantial impact on hippocampal function. This possibility is
consistent with accepted theoretical models of hippocampal
circuits [56,57,58] and experimental studies [59,60,61] implicating
the CA3 region of the hippocampus in key cognitive processes
underlying episodic memory, such as pattern separation (reducing
the overlap between similar neuronal representations) and pattern
completion (converging neuronal representations into a single
pattern, thus, facilitating their retrieval using only partial cues).
Therefore, it is plausible that the memory deficits observed in KA-
treated rats in this study can be accounted for, partly at least, by
the disruption of cognitive processes in CA3 neuronal networks,
which may be associated with the loss of neurons in this region.
Although in this study we have not estimated neuronal numbers
separately for the dorsal and ventral parts of the hippocampal
formation, visual inspection of the brain sections clearly showed
that neuronal loss associated with behavioral SE was more marked
in the ventral division of the dentate hilus than in its dorsal part
(Fig. 6). This finding is in line with a previous study demonstrating
that kainate-induced SE produces more severe loss at the temporal
(ventral) pole of the dentate hilus when compared to the septal
(dorsal) pole [28]. However, in the no-BSE group, the neurons of
the ventral hilus were less severely affected. This observation is
important for the interpretation of the finding that rats in the no-
BSE group, unlike those that had experienced motor SE, showed
normal behavior in the open-field, elevated plus-maze and fear-
conditioning tests. Indeed, considerable evidence suggests that the
ventral hippocampus has a preferential role in the regulation of
emotional behaviors in rodents [49]. Therefore, the different
extents of cell loss in the ventral hilus of rats from the BSE and no-
BSE groups can be related to the differences in their performance
on the anxiety-related tests. This explanation, however, should be
viewed with caution given that brain regions other than
hippocampus, e.g. the amygdala, play important roles in
emotional behaviors and were not analyzed histologically in the
present study. Another implication of this morphological observa-
tion is that the greater loss of neurons in the ventral dentate hilus
of BSE rats may be associated with the increased susceptibility to
the development of spontaneous motor seizures. Relevant to this
hypothesis is the finding by Inostrosa et al [9], who showed that
kainate-induced convulsive SE produces significant mossy fiber
sprouting only in the ventral part of the dentate gyrus, suggesting
an enhanced susceptibility of this hippocampal subdivision to
epileptogenesis [28]. Furthermore, it has been previously reported
that KA injection into the ventral hippocampus induces local
electrographic seizures, which rapidly propagate to the dorsal
hippocampus and cingulate cortex and are accompanied by severe
motor manifestations including stage 4 and 5 seizures on the
Racine scale [62]. In contrast, injection of KA into the dorsal
hippocampus induces only local electrographic seizures, which do
not propagate to the cingulate cortex and do not evoke behavioral
seizures [62]. Therefore, it is possible that the absence of
spontaneous motor seizures in no-BSE rats may be related to
the fact that the ventral hippocampus was better preserved in this
group when compared to the BSE group, in which all rats showed
spontaneous motor seizures. This, of course, does not mean that
the absence of convulsive SE after the treatment with KA
precludes the development of epilepsy later in life. Indeed, because
in the present study we did not perform EEG monitoring,
spontaneous subconvulsive seizures might have occurred in the no-
BSE group, but were not registered. In addition, the latency
between the kainate treatment and the onset of the first
spontaneous seizures may exceed the 5-month period of observa-
tion implemented in the current study [16].
In conclusion, this study was designed to compare the
behavioral and neuroanatomical outcomes in rats that developed
convulsive SE after kainate treatment to those that did not. It was
found that those rats in which KA did not induce motor signs of
SE were, however, impaired in hippocampal-dependent memory
tasks later in life, which can be explained by long-term functional
abnormalities in hippocampal circuits associated with the loss of
hilar cells and, probably, CA3 pyramidal neurons. However, the
extent of neuronal loss and the severity of cognitive deficits in this
group were far less striking than those observed in the rats that had
experienced motor SE. Thus, our findings add further weight to
the evidence from former studies in animal models [9,53] and
humans [4,6,63] showing that behavioral deficits in TLE correlate
with the extent of hippocampal damage.
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Please keep in mind that PLOS's Creative Commons Attribution License applies to striking 
images. As such, do not submit any figures or photos that have been previously copyrighted 
unless you have express written permission from the copyright holder to publish under the 
CCAL license. Note that all published materials in PLOS ONE are freely available online, and 
any third party is permitted to read, download, copy, distribute, and use these materials in any 
way, even commercially, with proper attribution. 
Care should be taken with the following image types in particular: 
1. PLOS ONE is unable to publish any images generated by Google software (Google Maps, 
Street View, and Earth) 
2. Maps in general are usually copyrighted, especially satellite maps 
3. Photographs 
4. Commercial or government images, slogans, or logos 
5. Images from Facebook or Twitter 
Authors must also take special care when submitting manuscripts that contain potentially 
identifying images of people. Identifying information should not be included in the manuscript 
unless the information is crucial and the individual has provided written consent by completing 
the Consent Form for Publication in a PLOS Journal (PDF). 
For license inquiries, e-mail license [at] plos.org. 
Tables 
Tables should be cited in ascending numeric order upon first appearance. Each table should 
be inserted immediately after the first paragraph in which it is cited in the article file. All tables 
should have a concise title. Footnotes can be used to explain abbreviations. Citations should 
be indicated using the same style as outlined above. Tables occupying more than one printed 
page should be avoided, if possible. Larger tables can be published as Supporting 
Information. Please ensure that table formatting conforms to our Guidelines for table 
preparation. 
3. Specific Reporting Guidelines 
Human Subject Research 
Methods sections of papers on research using human subject or samples must include ethics 
statements that specify: 
• The name of the approving institutional review board or equivalent committee(s). If approval 
was not obtained, the authors must provide a detailed statement explaining why it was not 
needed 
• Whether informed consent was written or oral. If informed consent was oral, it must be stated 
in the manuscript: 
o Why written consent could not be obtained 
o That the Institutional Review Board (IRB) approved use of oral consent 
o How oral consent was documented 
For studies involving humans categorized by race/ethnicity, age, disease/disabilities, religion, 
sex/gender, sexual orientation, or other socially constructed groupings, authors should: 
• Explicitly describe their methods of categorizing human populations 
• Define categories in as much detail as the study protocol allows 
• Justify their choices of definitions and categories, including for example whether any rules of 
human categorization were required by their funding agency 
• Explain whether (and if so, how) they controlled for confounding variables such as 
socioeconomic status, nutrition, environmental exposures, or similar factors in their analysis 
In addition, outmoded terms and potentially stigmatizing labels should be changed to more 
current, acceptable terminology. Examples: "Caucasian" should be changed to "white" or "of 
[Western] European descent" (as appropriate); "cancer victims" should be changed to 
"patients with cancer." 
For papers that include identifying, or potentially identifying, information, authors must 
download the Consent Form for Publication in a PLOS Journal (PDF), which the individual, 
parent, or guardian must sign once they have read the paper and been informed about the 
terms of PLOS open-access license. The signed consent form should not be submitted with 
the manuscript, but authors should securely file it in the individual's case notes and the 
methods section of the manuscript should explicitly state that consent authorization for 
publication is on file, using wording like: 
The individual in this manuscript has given written informed consent (as outlined in 
PLOS consent form) to publish these case details. 
For more information about PLOS ONE policies regarding human subject research, see 
the Publication Criteria and Editorial Policies. 
Clinical Trials 
Authors of manuscripts describing the results of clinical trials must adhere to 
the CONSORT reporting guidelines appropriate to their trial design, available on 
the CONSORT Statement website. Before the paper can enter peer review, authors must: 
1. Provide the registry name and number in the methods section of the manuscript 
2. Provide a copy of the trial protocol as approved by the ethics committee and a 
completed CONSORT checklist as Supporting Information (which will be published alongside 
the paper, if accepted). This should be named S1 CONSORT Checklist. 
3. Include the CONSORT flow diagram as the manuscript's "Fig. 1" 
Any deviation from the trial protocol must be explained in the paper. Authors must explicitly 
discuss informed consent in their paper, and we reserve the right to ask for a copy of the 
patient consent form. 
The methods section must include the name of the registry, the registry number, and the URL 
of your trial in the registry database for each location in which the trial is registered. 
For more information about PLOS ONE policies regarding clinical trials, see the Editorial 
Policies. 
Animal Research 
Methods sections of manuscripts reporting results of animal research must include required 
ethics statements that specify: 
• The full name of the relevant ethics committee that approved the work, and the associated 
permit number(s) (where ethical approval is not required, the manuscript should include a 
clear statement of this and the reason why) 
• Relevant details for efforts taken to ameliorate animal suffering 
For example: 
This study was carried out in strict accordance with the recommendations in the Guide 
for the Care and Use of Laboratory Animals of the National Institutes of Health. The 
protocol was approved by the Committee on the Ethics of Animal Experiments of the 
University of Minnesota (Permit Number: 27-2956). All surgery was performed under 
sodium pentobarbital anesthesia, and all efforts were made to minimize suffering. 
The organism(s) studied should always be stated in the abstract. Where research may be 
confused as pertaining to clinical research, the animal model should also be stated in the title. 
We ask authors to follow the ARRIVE (Animal Research: Reporting of In Vivo Experiments) 
guidelines for all submissions describing laboratory-based animal research and to upload a 
completed ARRIVE Guidelines Checklist to be published as supporting information. Please 
note that inclusion of a completed ARRIVE Checklist will be a formal requirement for 
publication at a later date. 
For more information about PLOS ONE policies regarding animal research, see 
the Publication Criteria and Editorial Policies. 
Observational and Field Studies 
Methods sections for submissions reporting on any type of field study must include ethics 
statements that specify: 
• Permits and approvals obtained for the work, including the full name of the authority that 
approved the study; if none were required, authors should explain why 
• Whether the land accessed is privately owned or protected 
• Whether any protected species were sampled 
• Full details of animal husbandry, experimentation, and care/welfare, where relevant 
For more information about PLOS ONE policies regarding observational and field studies, see 
the Publication Criteria and Editorial Policies. 
Cell Line Research 
Authors reporting research using cell lines should state when and where they obtained the 
cells, giving the date and the name of the researcher, cell line repository, or commercial 
source (company) who provided the cells, as appropriate. Authors must also include the 
following information for each cell line: 
For de novo (new) cell lines, including those given to the researchers a gift, authors must 
follow our policies for human subject research or animal research, as appropriate. The ethics 
statement must include: 
• Details of institutional review board or ethics committee approval; AND 
• For human cells, confirmation of written informed consent from the donor, guardian, or next of 
kin 
For established cell lines, the Methods section should include: 
• A reference to the published article that first described the cell line; AND/OR 
• The cell line repository or company the cell line was obtained from, the catalogue number, 
and whether the cell line was obtained directly from the repository/company or from another 
laboratory 
Authors should check established cell lines using the ICLAC Database of Cross-contaminated 
or Misidentified Cell Lines to confirm they are not misidentified or contaminated. Cell line 
authentication is recommended - e.g. by karyotyping, isozyme analysis, or short tandem 
repeats (STR) analysis - and may be required during peer review or after publication. 
Blots and Gels 
Authors of manuscripts reporting results from blots (including Western blots) and 
electrophoretic gels should follow these guidelines: 
• In accordance with PLOS ONE's policy on image manipulation, the image should not be 
adjusted in any way that could affect the scientific information displayed, e.g. by modifying the 
background or contrast 
• All blots and gels that support results reported in the manuscript should be provided 
• Original uncropped and unadjusted blots and gels, including molecular size markers, should 
be provided in either the figures or the supplementary files 
• Lanes should not be overcropped around the bands; the image should show most or all of the 
blot or gel. Any non-specific bands should be shown and an explanation of their nature should 
be given 
• The image should include all relevant controls, and controls should be run on the same blot or 
gel as the samples 
• A figure panel should not include composite images of bands originating from different blots 
or gels. If the figure shows non-adjacent bands from the same blot or gel, this should be 
clearly denoted by vertical black lines and the figure legend should provide details of how the 
figure was made 
 
Antibodies 
Manuscripts reporting experiments using antibodies should include the following information: 
• The name of each antibody, a description of whether it is monoclonal or polyclonal, and the 
host species 
• The commercial supplier or source laboratory 
• The catalogue or clone number and, if known, the batch number 
• The antigen(s) used to raise the antibody 
• For established antibodies, authors are encouraged to supply a stable public identifier from 
the Antibody Registry (www.antibodyregistry.org). 
Authors should also report the following experimental details: 
• The final antibody concentration or dilution 
• A reference to the validation study if the antibody was previously validated, and if not, details 
of how the authors validated the antibody for the applications and species used. Authors 
should consider adding information on new validations to a publicly available database such 
as Antibodypediaor CiteAb. 
 
Systematic Review/Meta-Analysis 
A systematic review paper, as defined by The Cochrane Collaboration, is a review of a clearly 
formulated question that uses explicit, systematic methods to identify, select, and critically 
appraise relevant research, and to collect and analyze data from the studies that are included 
in the review. These reviews differ substantially from narrative-based reviews or synthesis 
articles. Statistical methods (meta-analysis) may or may not be used to analyze and 
summarize the results of the included studies. 
Reports of systematic reviews and meta-analyses must include a completed PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist and flow 
diagram to accompany the main text. Blank templates are available here: 
• Checklist: PDF or Word document 
• Flow diagram: PDF or Word document 
Authors must also state in their "Methods" section whether a protocol exists for their 
systematic review, and if so, provide a copy of the protocol as Supporting Information and 
provide the registry number in the abstract. 
If your article is a Systematic Review or a Meta-Analysis you should: 
• State this in your cover letter 
• Select "Research Article" as your article type when submitting 
• Include the PRISMA flowchart as Fig. 1 (required where applicable) 
• Include the PRISMA checklist as Supporting Information 
 
Meta-Analysis of Genetic Association Studies 
Manuscripts reporting a meta-analysis of genetic association studies must report results of 
value to the field and should be reported according to the guidelines presented in “Systematic 
Reviews of Genetic Association Studies” by Sagoo et al. 
On submission, authors will be asked to justify the rationale for the meta-analysis and how it 
contributes to the base of scientific knowledge in the light of previously published results. 
Authors will also be asked to complete a checklist outlining information about the justification 
for the study and the methodology employed. Meta-analyses that replicate published studies 
will be rejected if the authors do not provide adequate justification. 
 
Paleontology and Archaeology Research 
Manuscripts reporting paleontology and archaeology research must include descriptions of 
methods and specimens in sufficient detail to allow the work to be reproduced. Data sets 
supporting statistical and phylogenetic analyses should be provided, preferably in a format 
that allows easy re-use. 
Specimen numbers and complete repository information, including museum name and 
geographic location, are required for publication. Locality information should be provided in 
the manuscript as legally allowable, or a statement should be included giving details of the 
availability of such information to qualified researchers. 
If permits were required for any aspect of the work, details should be given of all permits that 
were obtained, including the full name of the issuing authority. This should be accompanied 
by the following statement: 
All necessary permits were obtained for the described study, which complied with all 
relevant regulations. 
If no permits were required, please include the following statement: 
No permits were required for the described study, which complied with all relevant 
regulations. 
See the PLOS ONE Editorial Policies for more information regarding manuscripts describing 
paleontology and archaeology research. 
Software Papers 
Manuscripts describing software should provide full details of the algorithms designed. 
Describe any dependencies on commercial products or operating system. Include details of 
the supplied test data and explain how to install and run the software. A brief description of 
enhancements made in the major releases of the software may also be given. Authors should 
provide a direct link to the deposited software from within the paper. 
See the PLOS ONE Editorial Policies for more information about submitting manuscripts. 
Database Papers 
For descriptions of databases, provide details about how the data were curated, as well as 
plans for long-term database maintenance, growth, and stability. Authors should provide a 
direct link to the database hosting site from within the paper. 
See the PLOS ONE Editorial Policies for more information about submitting manuscripts 
describing databases. 
New Zoological Taxon 
For proper registration of a new zoological taxon, we require two specific statements to be 
included in your manuscript. 
In the Results section, the globally unique identifier (GUID), currently in the form of a Life 
Science Identifier (LSID), should be listed under the new species name, for example: 
Anochetus boltoni Fisher sp. nov. urn:lsid:zoobank.org:act:B6C072CF-1CA6-40C7-8396-
534E91EF7FBB 
You will need to contact Zoobank to obtain a GUID (LSID). Please do this as early as 
possible to avoid delay of publication upon acceptance of your manuscript. It is your 
responsibility to provide us with this information so we can include it in the final published 
paper. 
Please also insert the following text into the Methods section, in a sub-section to be called 
"Nomenclatural Acts": 
The electronic edition of this article conforms to the requirements of the amended 
International Code of Zoological Nomenclature, and hence the new names contained 
herein are available under that Code from the electronic edition of this article. This 
published work and the nomenclatural acts it contains have been registered in 
ZooBank, the online registration system for the ICZN. The ZooBank LSIDs (Life 
Science Identifiers) can be resolved and the associated information viewed through 
any standard web browser by appending the LSID to the prefix "http://zoobank.org/". 
The LSID for this publication is: urn:lsid:zoobank.org:pub: XXXXXXX. The electronic 
edition of this work was published in a journal with an ISSN, and has been archived 
and is available from the following digital repositories: PubMed Central, LOCKSS 
[author to insert any additional repositories]. 
All PLOS ONE articles are deposited in PubMed Central and LOCKSS. If your institute, or 
those of your co-authors, has its own repository, we recommend that you also deposit the 
published online article there and include the name in your article. 
New Botanical Taxon 
When publishing papers that describe a new botanical taxon, PLOS aims to comply with the 
requirements of the International Code of Nomenclature for algae, fungi, and plants (ICN). In 
association with the International Plant Names Index (IPNI), the following guidelines for 
publication in an online-only journal have been agreed such that any scientific botanical name 
published by us is considered effectively published under the rules of the Code. Please note 
that these guidelines differ from those for zoological nomenclature, and apply only to seed 
plants, ferns, and lycophytes. 
Effective January 2012, "the description or diagnosis required for valid publication of the 
name of a new taxon" can be in either Latin or English. This does not affect the requirements 
for scientific names, which are still to be Latin. 
Also effective January 2012, the electronic PDF represents a published work according to the 
ICN for algae, fungi, and plants. Therefore the new names contained in the electronic 
publication of a PLOS ONE article are effectively published under that Code from the 
electronic edition alone, so there is no longer any need to provide printed copies. 
Additional information describing recent changes to the Code can be found here. 
For proper registration of the new taxon, we require two specific statements to be included in 
your manuscript. 
In the Results section, the globally unique identifier (GUID), currently in the form of a Life 
Science Identifier (LSID), should be listed under the new species name, for example: 
Solanum aspersum S.Knapp, sp. nov. [urn:lsid:ipni.org:names:77103633-1] Type: 
Colombia. Putumayo: vertiente oriental de la Cordillera, entre Sachamates y San 
Francisco de Sibundoy, 1600-1750 m, 30 Dec 1940, J. Cuatrecasas 11471 (holotype, 
COL; isotypes, F [F-1335119], US [US-1799731]). 
PLOS ONE staff will contact IPNI to obtain the GUID (LSID) after your manuscript is accepted 
for publication, and this information will then be added to the manuscript during the production 
phase 
In the Methods section, include a sub-section called "Nomenclature" using the following 
wording: 
The electronic version of this article in Portable Document Format (PDF) in a work with 
an ISSN or ISBN will represent a published work according to the International Code of 
Nomenclature for algae, fungi, and plants, and hence the new names contained in the 
electronic publication of a PLOS ONE article are effectively published under that Code 
from the electronic edition alone, so there is no longer any need to provide printed 
copies. 
In addition, new names contained in this work have been submitted to IPNI, from where 
they will be made available to the Global Names Index. The IPNI LSIDs can be resolved 
and the associated information viewed through any standard web browser by 
appending the LSID contained in this publication to the prefix http://ipni.org/. The 
online version of this work is archived and available from the following digital 
repositories: [INSERT NAMES OF DIGITAL REPOSITORIES WHERE ACCEPTED 
MANUSCRIPT WILL BE SUBMITTED (PubMed Central, LOCKSS etc)]. 
All PLOS ONE articles are deposited in PubMed Central and LOCKSS. If your institute, or 
those of your co-authors, has its own repository, we recommend that you also deposit the 
published online article there and include the name in your article. 
New Fungal Taxon 
When publishing papers that describe a new fungal taxon name, PLOS aims to comply with 
the requirements of the International Code of Nomenclature for algae, fungi, and plants (ICN). 
The following guidelines for publication in an online-only journal have been agreed such that 
any scientific fungal name published by us is considered effectively published under the rules 
of the Code. Please note that these guidelines differ from those for zoological nomenclature. 
Effective January 2012, "the description or diagnosis required for valid publication of the 
name of a new taxon" can be in either Latin or English. This does not affect the requirements 
for scientific names, which are still to be Latin. 
Also effective January 2012, the electronic PDF represents a published work according to the 
ICN for algae, fungi, and plants. Therefore the new names contained in the electronic 
publication of a PLOS ONE article are effectively published under that Code from the 
electronic edition alone, so there is no longer any need to provide printed copies. 
Additional information describing recent changes to the Code can be found here. 
For proper registration of the new taxon, we require two specific statements to be included in 
your manuscript. 
In the Results section, the globally unique identifier (GUID), currently in the form of a Life 
Science Identifier (LSID), should be listed under the new species name, for example: 
Hymenogaster huthii. Stielow et al. 2010, sp. nov. 
[urn:lsid:indexfungorum.org:names:518624] 
You will need to contact either Mycobank or Index Fungorum to obtain the GUID (LSID). 
Please do this as early as possible to avoid delay of publication upon acceptance of your 
manuscript. It is your responsibility to provide us with this information so we can include it in 
the final published paper. Effective January 2013, all papers describing new fungal species 
must reference the identifier issued by a recognized repository in the protologue in order to be 
considered effectively published. 
In the Methods section, include a sub-section called "Nomenclature" using the following 
wording (this example is for taxon names submitted to MycoBank; please substitute 
appropriately if you have submitted to Index Fungorum): 
The electronic version of this article in Portable Document Format (PDF) in a work with 
an ISSN or ISBN will represent a published work according to the International Code of 
Nomenclature for algae, fungi, and plants, and hence the new names contained in the 
electronic publication of a PLOS ONE article are effectively published under that Code 
from the electronic edition alone, so there is no longer any need to provide printed 
copies. 
In addition, new names contained in this work have been submitted to MycoBank from 
where they will be made available to the Global Names Index. The unique MycoBank 
number can be resolved and the associated information viewed through any standard 
web browser by appending the MycoBank number contained in this publication to the 
prefix http://www.mycobank.org/MB/. The online version of this work is archived and 
available from the following digital repositories: [INSERT NAMES OF DIGITAL 
REPOSITORIES WHERE ACCEPTED MANUSCRIPT WILL BE SUBMITTED (PubMed 
Central, LOCKSS etc)]. 
All PLOS ONE articles are deposited in PubMed Central and LOCKSS. If your institute, or 
those of your co-authors, has its own repository, we recommend that you also deposit the 
published online article there and include the name in your article. 
Qualitative Research 
Qualitative research studies use non-quantitative methods to address a defined research 
question that may not be accessible by quantitative methods, such as people's 
interpretations, experiences, and perspectives. The analysis methods are explicit, systematic, 
and reproducible, but the results do not involve numerical values or use statistics. Examples 
of qualitative data sources include, but are not limited to, interviews, text documents, 
audio/video recordings, and free-form answers to questionnaires and surveys. 
Qualitative research studies should be reported in accordance to the Consolidated criteria for 
reporting qualitative research (COREQ) checklist. Further reporting guidelines can be found 
in the Equator Network's Guidelines for reporting qualitative research. 	  
Hippocampal neurodegeneration in kainate-treated rats with 
and without recurrent motor seizures 
 
J. Quesado, G. Maia, N.Lukoyanov 
 
Department of Anatomy, Faculty of Medicine, University of Porto, Portugal. 
Temporal lobe epilepsy (TLE) is often associated with hippocampal sclerosis (cell loss) 
and other structural changes in the medial temporal lobe region. Generalized motor 
seizures are present in severe cases of TLE. As TLE is progressive this seizures can 
become intractable. It has also been repeatedly reported that TLE patients with 
hippocampal sclerosis may show learning and memory deficits, increased anxiety, 
depression and mood disorders. Thus, it seems reasonable that these behavioral changes 
are secondary to the TLE-related hippocampal neurodegeneration. 
Animal models of TLE replicate the majority of •the neuropathological aspects of 
TLE. Kainic acid (KA) is a specific agonist for the ionotropic glutamate receptor. When 
injected in rats, KA induces acute status epilepticus (SE). However, a large percentage 
of the injected animals don't develop RMS and are usually excluded from further 
analyses. The purpose of this study was to directly compare the neuroanatomical 
outcomes in KA-treated rats that developed RMS to those that did not. To address this 
issue, absolute numbers of neurons in the dentate gyrus hilus and pyramidal layers of 
the hippocampus proper were estimated using stereological approaches in order to 
compare the hippocampal cell loss among the two groups. 
Male Wistar rats were injected with 5 mg/kg of KA until the onset of SE (n=28). Rats in 
the control group were injected with saline (n = 8). Across the 5-month recovery period 
the behavior of rats was videorecorded. If a rat showed two or more spontaneous motor 
seizures of stage 4 or 5 on the Racine scale, it was assigned to the RMS group. 
Remaining animals were assigned to the no-RMS group. From the 28 rats that were 
treated with KA, 8 rats have died and 9 rats developed spontaneous motor seizures 
(assigned to RMS group). No behavioral seizures were detected in the 11 remaining 
KA-treated rats (assigned to no-RMS group). After perfusion of the animals, their 
brains were sectioned in the coronal plane with 40 μm. The sections were stained with 
Giemsa and used for histological analysis. 
The total number of neurons was estimated applying the optical fractionator method. 
The boundaries of the hilus of the dentate gyrus and the CA3 and CA1 hippocampal 
fields were consistently defined at all levels along the rostrocaudal axis of the brain 
based on the cell morphology and cytoarchitectonic criteria. Estimations were carried 
out using the C.A.S.T.-Grid System (Olympus, Denmark). 
It was found that the total number of neurons in the hilus of the dentate gyrus and in the 
CA3 and CA1 fields of the hippocampus proper were significantly different in rats with 
or without seizures. Post-hoc comparisons showed that in animals from the RMS group 
there was a significant neuron loss in the dentate hilus and hippocampal CA3 and CA1 
fields. In sharp contrast, in rats from the no-RMS group there was a significant neuron 
loss only in the dentate hilus, but not in the hippocampal pyramidal fields. 
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2011-2012, Project PEst-OE/SAU/UI0121/2011. 

